We've upgraded AI Tools on TaxTMI with two powerful modes:
1. Basic • Quick overview summary answering your query with references• Category-wise results to explore all relevant documents on TaxTMI
2. Advanced • Includes everything in Basic • Detailed report covering: - Overview Summary - Governing Provisions [Acts, Notifications, Circulars] - Relevant Case Laws - Tariff / Classification / HSN - Expert views from TaxTMI - Practical Guidance with immediate steps and dispute strategy
• Also highlights how each document is relevant to your query, helping you quickly understand key insights without reading the full text.Help Us Improve - by giving the rating with each AI Result:
Appeal allowed for undervaluation of physician's samples in Central Excise duty case. The appeal was allowed in favor of M/s.Gena Pharmaceuticals Ltd. in a case concerning the undervaluation of physician's samples for Central Excise duty ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Appeal allowed for undervaluation of physician's samples in Central Excise duty case.
The appeal was allowed in favor of M/s.Gena Pharmaceuticals Ltd. in a case concerning the undervaluation of physician's samples for Central Excise duty calculation. The Judicial Member noted the lack of evidence indicating intentional evasion of duty, leading to the waiver of penalties under Rule 25 of the Central Excise Rules, 2002, and Section 11AC of the Central Excise Act, 1944. The decision hinged on the correct valuation of the samples and the absence of deliberate intent to evade duty, as the appellants had already paid the duty and interest.
Issues: Undervaluation of physician's samples for Central Excise duty calculation under Section 4 instead of Section 4A.
Analysis: The case involved M/s.Gena Pharmaceuticals Ltd., accused of undervaluing physician's samples for Central Excise duty calculation. The issue revolved around whether the appellants correctly determined the assessable value of physician's samples under Section 4A of the Central Excise Act, 1944, or if they should have used Section 4. The commodities in question fell under Chapter Heading/Sub-heading No.3003.10 and 3003.20 of the Central Excise Tariff Act, 1985, which were subjected to MRP valuation under Section 4A from 08.01.2005. The appellants cleared the samples based on an earlier Board's Circular instead of the subsequent one, leading to a dispute.
Upon hearing the arguments and reviewing the records, the Judicial Member noted that there was no evidence to suggest that the appellants intentionally evaded duty. Reference was made to a Supreme Court case highlighting that penalties can be imposed for deliberate deception to evade duty. However, as the appellants had already paid the Central Excise duty and interest, the Judicial Member concluded that there was no deliberate intent to evade duty. Consequently, the penalty under Rule 25 of the Central Excise Rules, 2002, along with Section 11AC of the Central Excise Act, 1944, was waived, and the appeal was allowed in favor of the appellants.
In summary, the judgment focused on the correct valuation of physician's samples for Central Excise duty calculation and whether there was deliberate intent to evade duty. The decision to waive the penalty was based on the lack of evidence showing intentional misconduct by the appellants, as they had already fulfilled their duty liability.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.